Sinovac Biotech (SVA) Files 10M Share Shelf
Sinovac Biotech Ltd. (NYSE: SVA) filed a shelf registration to offer up to 10 million shares of common stock on form F-3 with the SEC.
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases in China.
Create E-mail AlertRelated Categories
Equity OfferingsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
